Gentel plans to add 50 new kits to its product portfolio by the end of the year, as it transforms itself from being a services-oriented business to one that derives the bulk of its sales from products.
The collaboration covers Protein Biotechnologies' SomaPlex arrays and Gentel Bioscience's APiX View Detection Kits, which were launched this week.
Illumina's VeraCode ADME Core Panel, Aushon Biosystems' human vascular injury panels, BioServe and Protein Biotechnologies' SomaPlex reverse-phase protein microarrays
The SomaPlex Reverse Phase Protein Microarray is the first product stemming from a collaboration between the two firms, and additional arrays are planned for launch throughout 2010.
In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.
An opinion piece at Bloomberg discusses China's stance on genomic research.
Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.
Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.